IVE brings you the latest information about intravenous cancer therapies. We are a resource established by NCODA with their partners and sponsors for you and your doctors to help communicate vital information about these medications.
Helping To Bridge The Gap
Intravenous Education (IVE) was conceived by NCODA as a resource to provide information about intravenous cancer therapies and their side effects to both cancer patients and caregivers. We know having cancer or caring for someone with it can be overwhelming, but finding reliable information about the medications should not be. We aim to help caregivers by providing them a tool to pass on to their patients with cancer that will answer drug related questions and help empower patients to become a more active participant in their cancer treatment.
Frequently Asked Questions
How often are the IVE handouts updated?
The IVE team reviews the handouts on a routine basis, but no less than once a year. We strive to stay up-to-date on major changes, and we often make updates on an as-needed basis in crucial scenarios.
Can I print the IVE documents?
The IVE documents are available for print and download. In their electronic format, the documents are editable to include additional counseling notes and/or specific contact information.
Working Together For You
NCODA's guiding values of being patient-centered and collaborative are at the heart of every one of our initiatives. We are leading in expertise, quality standards, and the sharing of best practices with all medically-integrated pharmacy teams and stakeholders involved in the care of cancer patients.
The Hematology/Oncology Pharmacy Association (HOPA) supports pharmacy practitioners and seeks to promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer.
Association of Community Cancer Centers
The Association of Community Cancer Centers (ACCC) promotes the entire continuum of quality cancer care for our patients and our communities. Since 1974, ACCC has been helping oncology professionals adapt to the complex changes of delivering quality cancer care.